IDH-WILDTYPE GLIOBLASTOMA
Clinical trials for IDH-WILDTYPE GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new IDH-WILDTYPE GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for IDH-WILDTYPE GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive brain tumors? drug trial targets recurrent glioblastoma
Disease control Recruiting nowThis early-stage trial tests a new drug called ERAS-801 in 10 adults with a type of aggressive brain cancer (glioblastoma) that has come back or worsened. The drug targets a specific protein (EGFR) found on many of these tumor cells and is designed to reach the brain. The main go…
Matched conditions: IDH-WILDTYPE GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Brain cancer study asks: is morning or evening chemo better?
Symptom relief Recruiting nowThis study looks at whether taking the chemotherapy drug temozolomide at a specific time of day (morning vs evening) helps people with a type of brain cancer called glioblastoma. About 50 adults who have already had surgery and radiation will be randomly assigned to take their ch…
Matched conditions: IDH-WILDTYPE GLIOBLASTOMA
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated May 26, 2026 08:19 UTC